Our funding programs support early stage, Ohio-based companies to achieve success.

Ischemia Care

Ischemia Care is a clinical stage capital efficient, diagnostic laboratory commercializing a blood test called ISCDX for cause of stroke and TIA, including atrial fibrillation. Ischemia Care is currently enrolling in a clinical trial (NCT0214896) designed to lead to commercial adoption of ISCDX through company owned CLIA lab.

view all portfolio companies

Global Cardiovascular Innovation Center